Clinical trial
Quality of Recovery After Major Breast Cancer Surgery: a Prospective Multicentre Randomized Triple Blinded Trial Comparing Erector Spinae Plane Block and Intravenous Lidocaine Infusion
NCT06490718 is registered in ClinicalTrials.gov with Chinese University of Hong Kong as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Quality of Recovery After Major Breast Cancer Surgery: a Prospective Multicentre Randomized Triple Blinded Trial Comparing Erector Spinae Plane Block and Intravenous Lidocaine Infusion
- Lead sponsor
- Chinese University of Hong Kong
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 25, 2024
- Completion date
- July 20, 2025
- Enrollment
- 80 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.